Skip to main content
Premium Trial:

Request an Annual Quote

Diaceutics Inks Deal for BioReference Labs Dx Data

NEW YORK (GenomeWeb) – Consulting firm Diaceutics announced today that it has signed an agreement to obtain real-time patient testing data from BioReference Laboratories, which it will use to help pharmaceutical industry clients accelerate the rollouts of new cancer drugs.

Under the terms of the five-year deal, Diaceutics will have access to BioReference diagnostic data from 50,000 patient samples per day, which it will combine with existing datasets it has accumulated through partnerships with other labs. The firm will use the aggregated data to help its customers better understand the testing patterns of physicians considering precision medicine therapies for patients.

Additional terms were not disclosed.

"Diagnostic data from laboratories like BioReference help pharmaceutical companies better understand the testing journey that patients go on in the often difficult search for a targeted therapy determined by biomarkers," Diaceutics CEO Peter Keeling said in a statement. "That information allows pharma to pinpoint patients that need to be on a specific ... drug, accelerate speed to market for new drugs, and improve patient outcomes."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.